We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Routine Blood Glucose Measurements Can Accurately Estimate HbA1c

By LabMedica International staff writers
Posted on 06 May 2014
Print article
Image: A typical clinical laboratory diabetes analyzer (Photo courtesy of Innovastar).
Image: A typical clinical laboratory diabetes analyzer (Photo courtesy of Innovastar).
Image: The A1CNow monitoring system for glycated hemoglobin (HbA1c) levels (Photo courtesy of Bayer).
Image: The A1CNow monitoring system for glycated hemoglobin (HbA1c) levels (Photo courtesy of Bayer).
Glycated hemoglobin or HbA1c is the standard measurement for assessing glycemic control over time in people with diabetes and blood levels of HbA1c are typically measured every few months in a laboratory.

The relationship between HbA1c and average glucose levels could determine whether HbA1c could be expressed and reported as average glucose in the same units as used in self-monitoring which could increase individuals' motivation to improve diabetes control.

Scientists at the University of Virginia (Charlottesville, VA, USA) working with those at Sanofi-Aventis Deutschland GmbH (Frankfurt, Germany) developed a data-based model that accurately estimates HbA1c using self-monitored blood glucose (SMBG) readings. The computer algorithm they developed was based on a training data set drawn from 379 subjects and then evaluated for accuracy on an independent test data set. The average HbA1c level was 7.6% (± 1.1%), with minimum and maximum values of 5.2% and 12.2%, respectively.

A conceptually new, clinically viable procedure was developed for real-time tracking of average glycaemia from self-monitoring data. The average glucose tracing can then be converted into running estimates of HbA1c, which can be presented to the patient daily. The computational demands of the procedure are low and therefore readily implementable into devices with limited processing power, such as home SMBG meter.

The procedure, tracking average glycaemia and HbA1c in real time, could provide valuable assistance to the daily optimization of diabetes control. The procedure is not intended as a substitute for laboratory assessments of HbA1c and it should be viewed as a surrogate measure that allows convenient tracing of average glucose, readily implementable in a point-of-care SMBG device.

Satish Garg, MD, a professor of medicine and pediatrics at the University of Colorado (Denver, CO, USA) said, “Patients are used to a HbA1c result from their doctor visits, and this study highlights simple estimated HbA1c values from SMBG data. This may become an important tool for improved patient self-management.” The study was published on April 23, 2014, in the journal Diabetes Technology & Therapeutics.

Related Links:

University of Virginia 
Sanofi-Aventis Deutschland GmbH 
University of Colorado


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.